Resistance to rifampicin: a review

[1]  R. Melano,et al.  Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis , 2014, Journal of Clinical Microbiology.

[2]  L. Rothman-Denes.  Structure of Escherichia coli RNA polymerase holoenzyme at last , 2013, Proceedings of the National Academy of Sciences.

[3]  M. Iademarco.  Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013 , 2013, MMWR. Morbidity and mortality weekly report.

[4]  G. Kahlmeter,et al.  Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact? , 2013, The Journal of antimicrobial chemotherapy.

[5]  Ken Kasahara,et al.  Activation and Products of the Cryptic Secondary Metabolite Biosynthetic Gene Clusters by Rifampin Resistance (rpoB) Mutations in Actinomycetes , 2013, Journal of bacteriology.

[6]  Shengfen Wang,et al.  Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis , 2012, Antimicrobial Agents and Chemotherapy.

[7]  G. Kahlmeter,et al.  Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. , 2012, Bulletin of the World Health Organization.

[8]  J. Marimón,et al.  Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples. , 2011, The Journal of antimicrobial chemotherapy.

[9]  L. Cui,et al.  Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus , 2011, Journal of Clinical Microbiology.

[10]  Ronald N. Jones,et al.  In Vitro Activity and Single-Step Mutational Analysis of Rifamycin SV Tested against Enteropathogens Associated with Traveler's Diarrhea and Clostridium difficile , 2010, Antimicrobial Agents and Chemotherapy.

[11]  K. Brodolin,et al.  Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. , 2010, International journal of antimicrobial agents.

[12]  J. Ishikawa,et al.  Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance , 2010, The Journal of Antibiotics.

[13]  P. V. van Helden,et al.  A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance , 2009, Antimicrobial Agents and Chemotherapy.

[14]  P. Alifano,et al.  Activation of Dormant Bacterial Genes by Nonomuraea sp. Strain ATCC 39727 Mutant-Type RNA Polymerase , 2008, Journal of bacteriology.

[15]  T. Dick,et al.  Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. , 2008, Journal of Antimicrobial Chemotherapy.

[16]  Wayne L. Nicholson,et al.  Uncovering New Metabolic Capabilities of Bacillus subtilis Using Phenotype Profiling of Rifampin-Resistant rpoB Mutants , 2007, Journal of bacteriology.

[17]  K. Chiba,et al.  Contribution of rpoB2 RNA Polymerase β Subunit Gene to Rifampin Resistance in Nocardia Species , 2006, Antimicrobial Agents and Chemotherapy.

[18]  B. Coulombe,et al.  Structural Perspective on Mutations Affecting the Function of Multisubunit RNA Polymerases , 2006, Microbiology and Molecular Biology Reviews.

[19]  C. Fishwick,et al.  Molecular Genetic and Structural Modeling Studies of Staphylococcus aureus RNA Polymerase and the Fitness of Rifampin Resistance Genotypes in Relation to Clinical Prevalence , 2006, Antimicrobial Agents and Chemotherapy.

[20]  Y. Kook,et al.  Mechanism of natural rifampin resistance of Streptomyces spp. , 2005, Systematic and applied microbiology.

[21]  J. Sackoff,et al.  Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  D. Jin,et al.  Cross-Resistance of Escherichia coli RNA Polymerases Conferring Rifampin Resistance to Different Antibiotics , 2005, Journal of bacteriology.

[23]  K. Severinov,et al.  Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase , 2005, The EMBO journal.

[24]  C. Çavuşoğlu,et al.  In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  F. Chang,et al.  Mutations of the rpoB gene in rifampicin-resistant Streptococcus pneumoniae in Taiwan. , 2004, The Journal of antimicrobial chemotherapy.

[26]  V. V. Gubanov,et al.  Primary structure of Escherichia coli RNA polymerase nucleotide substitution in the β subunit gene of the rifampicin resistant rpoB255 mutant , 2004, Molecular and General Genetics MGG.

[27]  Molecular basis of rifampicin resistance in Haemophilus influenzae. , 2003, The Journal of antimicrobial chemotherapy.

[28]  T. Sirisanthana,et al.  Emergence of Rifampin-Resistant Rhodococcus equi with Several Types of Mutations in the rpoB Gene among AIDS Patients in Northern Thailand , 2003, Journal of Clinical Microbiology.

[29]  T. Wichelhaus,et al.  Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.

[30]  G. French,et al.  Rifampin Resistance in Mycobacterium kansasii Is Associated with rpoB Mutations , 2001, Antimicrobial Agents and Chemotherapy.

[31]  L. Stamm,et al.  Natural Rifampin Resistance in Treponema spp. Correlates with Presence of N531 in RpoB Rif Cluster I , 2001, Antimicrobial Agents and Chemotherapy.

[32]  R. Leclercq,et al.  Characterization of Mutations in the rpoB Gene Associated with Rifampin Resistance in Rhodococcus equiIsolated from Foals , 2001, Journal of Clinical Microbiology.

[33]  J. Cove,et al.  Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.

[34]  G. La Rosa,et al.  Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. , 2001, The Journal of antimicrobial chemotherapy.

[35]  S. Niemann,et al.  Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis Isolates , 2001, Journal of Clinical Microbiology.

[36]  J. T. Crawford,et al.  Characterization of Spontaneous, In Vitro-Selected, Rifampin-Resistant Mutants of Mycobacterium tuberculosisStrain H37Rv , 2000, Antimicrobial Agents and Chemotherapy.

[37]  T. Wichelhaus,et al.  Molecular Characterization of rpoBMutations Conferring Cross-Resistance to Rifamycins on Methicillin-Resistant Staphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.

[38]  K. Klugman,et al.  Molecular Basis of Rifampin Resistance inStreptococcus pneumoniae , 1999, Antimicrobial Agents and Chemotherapy.

[39]  D. Raoult,et al.  Characterization of Mutations in therpoB Gene in Naturally Rifampin-ResistantRickettsia Species , 1999, Antimicrobial Agents and Chemotherapy.

[40]  S. Gillespie,et al.  Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis , 1999, Antimicrobial Agents and Chemotherapy.

[41]  C. Tribuddharat,et al.  Integron-Mediated Rifampin Resistance inPseudomonas aeruginosa , 1999, Antimicrobial Agents and Chemotherapy.

[42]  P. Courvalin,et al.  Characterization of Mutations in therpoB Gene That Confer Rifampin Resistance inStaphylococcus aureus , 1998, Antimicrobial Agents and Chemotherapy.

[43]  D. Jin,et al.  The rpoB mutants destabilizing initiation complexes at stringently controlled promoters behave like "stringent" RNA polymerases in Escherichia coli. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Chandrasekaran,et al.  Plasmid-mediated rifampicin resistance in Pseudomonas fluorescens. , 1998, Journal of medical microbiology.

[45]  S. Kohno,et al.  Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. , 1998, The Journal of antimicrobial chemotherapy.

[46]  E. Dabbs,et al.  Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic , 1997, Antimicrobial agents and chemotherapy.

[47]  H. Aramaki,et al.  Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. , 1996, FEMS microbiology letters.

[48]  S. Kohno,et al.  Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan , 1996, Antimicrobial agents and chemotherapy.

[49]  F. Laigret,et al.  Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase beta-subunit gene , 1996, Antimicrobial agents and chemotherapy.

[50]  K. Severinov,et al.  The β Subunit Rif-cluster I Is Only Angstroms Away from the Active Center of Escherichia coli RNA Polymerase * , 1995, The Journal of Biological Chemistry.

[51]  C. Price,et al.  Streptolydigin Resistance Can Be Conferred by Alterations to Either the β or β′ Subunits of Bacillus subtilis RNA Polymerase (*) , 1995, The Journal of Biological Chemistry.

[52]  K. Severinov,et al.  Streptolydigin-resistant Mutants in an Evolutionarily Conserved Region of the β′ Subunit of Escherichia coli RNA Polymerase (*) , 1995, The Journal of Biological Chemistry.

[53]  J. Musser,et al.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights , 1995, Clinical microbiology reviews.

[54]  K. Severinov,et al.  The b Subunit Rif-cluster I Is Only Angstroms Away from the Active Center of Escherichia coli RNA Polymerase* , 1995 .

[55]  K. Severinov,et al.  Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. T. Crawford,et al.  Characterization of rifampin-resistance in pathogenic mycobacteria , 1994, Antimicrobial Agents and Chemotherapy.

[57]  T. Pennington,et al.  Molecular characterization of rifampin-resistant Neisseria meningitidis , 1994, Antimicrobial Agents and Chemotherapy.

[58]  J. Musser,et al.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas , 1994, Journal of clinical microbiology.

[59]  C. Gross,et al.  Four contiguous amino acids define the target for streptolydigin resistance in the beta subunit of Escherichia coli RNA polymerase. , 1993, The Journal of biological chemistry.

[60]  K. Severinov,et al.  Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. , 1993, Journal of Biological Chemistry.

[61]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[62]  S. Cole,et al.  Molecular basis of rifampin resistance in Mycobacterium leprae , 1993, Antimicrobial Agents and Chemotherapy.

[63]  R. Landick,et al.  Amino acid changes in conserved regions of the beta-subunit of Escherichia coli RNA polymerase alter transcription pausing and termination. , 1990, Genes & development.

[64]  W. Wehrli,et al.  Resistance of Escherichia coli to rifampicin and sorangicin A--a comparison. , 1990, The Journal of antibiotics.

[65]  C. Gross,et al.  Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli , 1989, Journal of bacteriology.

[66]  Y. Nakamura,et al.  Effects of rifampicin resistant rpoB mutations on antitermination and interaction with nusA in Escherichia coli. , 1988, Journal of molecular biology.

[67]  C. Gross,et al.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. , 1988, Journal of molecular biology.

[68]  A. Nagata,et al.  Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis , 1985, Antimicrobial Agents and Chemotherapy.

[69]  H. Bremer,et al.  rpoB mutation in Escherichia coli alters control of ribosome synthesis by guanosine tetraphosphate , 1983, Journal of bacteriology.

[70]  V. V. Gubanov,et al.  The primary structure of Escherichia coli RNA polymerase. Nucleotide sequence of the rpoB gene and amino-acid sequence of the beta-subunit. , 1981, European journal of biochemistry.

[71]  C. Yanofsky,et al.  Rifampin resistance mutations that alter the efficiency of transcription termination at the tryptophan operon attenuator , 1981, Journal of bacteriology.

[72]  Ovchinnikov IuA,et al.  [Primary structure of Escherichia coli RNA-polymerase. Nucleotide sequence of gene rpoB and amino acid sequence of the beta-subunit]. , 1980 .

[73]  A. Sonenshein,et al.  Initiation of transcription in vitro inhibited by lipiarmycin. , 1979, Journal of molecular biology.

[74]  S. Harmon,et al.  Genetic analysis of Staphylococcus aureus RNA polymerase mutants , 1979, Journal of bacteriology.

[75]  K. Burtis,et al.  Reconstitution studies show that rifampicin resistance is determined by the largest polypeptide of Bacillus subtilis RNA polymerase. , 1977, The Journal of biological chemistry.

[76]  K. Scheit,et al.  Studies of the topography of the binding site of DNA-dependent RNA polymerase from Escherichia coli for the antibiotic rifamycin SV. , 1977, European journal of biochemistry.

[77]  T. Yura,et al.  Altered nutritional requirements associated with mutations affecting the structures of ribonucleic acid polymerase in Lactobacillus casei , 1976, Journal of bacteriology.

[78]  R. White,et al.  Lipiarmycin, a new antibiotic from Actinoplanes III. Mechanism of action. , 1975, The Journal of antibiotics.

[79]  F. Parenti,et al.  LIPIARMYCIN, A NEW ANTIBIOTIC FROM ACTINOPLANES , 1975 .

[80]  A. Sonenshein,et al.  Isolation and Characterization of Rifampin-Resistant and Streptolydigin-Resistant Mutants of Bacillus subtilis with Altered Sporulation Properties , 1974, Journal of bacteriology.

[81]  M. Artenstein,et al.  Mutation of gonococci and meningococci in vitro to rifampin (rifampicin) resistance. , 1972, The British journal of venereal diseases.

[82]  G. Lancini,et al.  Mechanism of Action of Rifampin on Mycobacterium smegmatis , 1971, Journal of bacteriology.

[83]  J. Davies,et al.  The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. , 1971, The Journal of infectious diseases.

[84]  A. Malmborg,et al.  Rifampicin Compared with Penicillin in the Treatment of Gonorrhea , 1971 .

[85]  W. Lester,et al.  Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections. , 1970, The New England journal of medicine.

[86]  W. Zillig,et al.  Reconstitution of bacterial DNA‐dependent RNA‐polymerase from isolated subunits as a tool for the elucidation of the role of the subunits in transcription , 1970, FEBS letters.

[87]  H. David,et al.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. , 1970, Applied microbiology.

[88]  R. Doi,et al.  Bacillus subtilis mutant altered in spore morphology and in RNA polymerase activity. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[89]  W. Zillig,et al.  A rifampicin resistent rna‐polymerase from E. coli altered in the β‐subunit , 1969 .

[90]  W. Wehrli,et al.  Interaction of rifamycin with bacterial RNA polymerase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Turck,et al.  Laboratory and clinical evaluation of rifampicin. , 1968, The American journal of the medical sciences.

[92]  K. Nitta,et al.  STREPTOVARICIN- AND RIFAMPIGIN-RESISTANGE OF RNA POLYMERASE IN A RESISTANT CLONE OF ESCHERICHIA COLI B , 1968 .